Radiology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

This Article
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Molitch, H. I.
Right arrow Articles by vanSonnenberg, E.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Molitch, H. I.
Right arrow Articles by vanSonnenberg, E.

Radiology, Vol 194, 343-347, Copyright © 1995 by Radiological Society of North America

ARTICLES

Percutaneous sclerotherapy of lymphangiomas

HI Molitch, EC Unger, CL Witte and E vanSonnenberg
Department of Radiology, University of Arizona, Tucson 85724.

PURPOSE: The authors report their experience with percutaneous image- guided sclerotherapy for treatment of unresectable lymphangiomas. MATERIALS AND METHODS: Five patients with unresectable lymphangiomas of the pelvis (n = 2), neck (n = 1), abdomen (n = 1), or leg (n = 1) were treated at two medical centers with sclerotherapy, with use of doxycycline as the sclerosant. Computed tomography was used to guide the procedures, with supplemental lymphoscintigraphy, ultrasound, and magnetic resonance imaging used as needed. RESULTS: Symptomatic relief of lymphedema, lymphorrhea, or a decrease in size of lymphatic pools was achieved, to varying degrees, in the five patients. Follow-up is ongoing, and further sclerotherapy may be indicated as the clinical course dictates. CONCLUSION: Percutaneous sclerotherapy with doxycycline is safe and appears effective for palliative treatment of unresectable lymphangiomas on the basis of our initial clinical experience.


This article has been cited by other articles:


Home page
 Ann. N. Y. Acad. Sci.Home page
F. BLEI
Congenital Lymphatic Malformations
Ann. N.Y. Acad. Sci., May 1, 2008; 1131(1): 185 - 194.
[Abstract] [Full Text] [PDF]

Home page
 CLIN PEDIATRHome page
G. A. Wirth and M. J. Sundine
Slow-Flow Vascular Malformations
Clinical Pediatrics, March 1, 2007; 46(2): 109 - 120.
[PDF]

Home page
 RadioGraphicsHome page
C. L. Witte, M. H. Witte, E. C. Unger, W. H. Williams, M. J. Bernas, G. C. McNeill, and A. M. Stazzone
Advances in Imaging of Lymph Flow Disorders
RadioGraphics, November 1, 2000; 20(6): 1697 - 1719.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Respir. Crit. Care Med.Home page
J. L. FAUL, G. J. BERRY, T. V. COLBY, S. J. RUOSS, M. B. WALTER, G. D. ROSEN, and T. A. RAFFIN
Thoracic Lymphangiomas, Lymphangiectasis, Lymphangiomatosis, and Lymphatic Dysplasia Syndrome
Am. J. Respir. Crit. Care Med., March 1, 2000; 161(3): 1037 - 1046.
[Full Text] [PDF]

Home page
 Am. J. Roentgenol.Home page
L. F. Donnelly, D. M. Adams, and G. S. Bisset III
Vascular Malformations and Hemangiomas: A Practical Approach in a Multidisciplinary Clinic
Am. J. Roentgenol., March 1, 2000; 174(3): 597 - 608.
[Full Text] [PDF]

Home page
 VASC ENDOVASCULAR SURGHome page
J. R. McShannic and P. J. O'Hara
Management of Femoral Lymphatic Complications Following Synthetic Lower Extremity Revascularization: Early and Late Results
Vascular and Endovascular Surgery, November 1, 1997; 31(6): 703 - 711.
[Abstract] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
RADIOLOGY RADIOGRAPHICS RSNA JOURNALS ONLINE
Copyright © 1995 by the Radiological Society of North America.